RELIVERGEN

Live / Registered — International registration cancelled — extension of protection cancelled (as of 12 Sept 2021)

What this means for you

Registered since 01 Jan 2013. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79108170
Registration number
4266253
Mark type
Stylized text
Filed
12 Sept 2011
Published for opposition
16 Oct 2012
Registered
01 Jan 2013
Attorney of record
Michelle L. Visser

Goods and services

  • Class 001 — Chemicals: Plant extracts for use in the manufacture of pharmaceutical preparations; plant extracts for use in the manufacture of foodstuffs; chemical ingredients for use in the manufacture of anti-viral, anti-inflammatory, immuno-modulatory and anti-fibrotic medications
  • Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations used in the treatment of liver disorders, including chronic hepatitis C and fatty liver disease; pharmaceuticals, namely anti-viral, anti-inflammatory, immuno-modulatory and anti-fibrotic medications

Owner

Prosecution history

  • 09 Apr 2022 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
  • 09 Apr 2022 — DEATH OF INTERNATIONAL REGISTRATION
  • 26 Jun 2020 — TOTAL INVALIDATION PROCESSED BY THE IB
  • 01 Jun 2020 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
  • 31 May 2020 — INVALIDATION PROCESSED
  • 02 Apr 2020 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
  • 02 Aug 2019 — CANCELLED SECTION 71
  • 01 Jan 2018 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
  • 28 Jul 2016 — NEW REPRESENTATIVE AT IB RECEIVED
  • 21 Jul 2014 — NEW REPRESENTATIVE AT IB RECEIVED
  • 06 May 2013 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 13 Apr 2013 — FINAL DISPOSITION NOTICE SENT TO IB
  • 13 Apr 2013 — FINAL DISPOSITION PROCESSED
  • 01 Apr 2013 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 01 Jan 2013 — REGISTERED-PRINCIPAL REGISTER

View this trademark record on Marksy